Interaction of Polyethyleneimines with Fibrinogen and Erythrocyte Membrane
Dagen Zhong,Yuanming Zhang,Qinhua Zuo,Zonghua Liu,Wei Xue
DOI: https://doi.org/10.1080/1539445x.2013.812873
2014-01-01
Soft Materials
Abstract:For any administered or implanted biomaterials in contact with blood tissue, they first and unavoidably encounter plasma components and blood cell membranes, and immediately strong or weak interactions between them will be initiated. Therefore, the safety issue of the biomaterials for blood tissue should be given a full consideration. In this study, the effects of the gene carrier polyethyleneimines (PEIs) differing in molecular weight and shape (branched or linear) on plasma proteins and blood cell membranes were investigated in detail. On one hand, the structure, conformation, and biofunction of fibrinogen as an important plasma protein were examined by UV-vis, fluorescence and circular dichroism spectroscopy, and fibrin polymerization test, respectively. Furthermore, the rheological behavior of whole blood containing the PEIs was also evaluated. On the other hand, the morphology, surface roughness, membrane proteins, and enzyme activity on erythrocyte membrane after the PEIs-treatment were also examined by using atomic force microscopy, electrophoresis, and enzyme activity test, respectively. The results reveal that, the PEIs alter the struture and conformation of fibrinogen and then modify the fibrin polymerization process. As a result, the clotting function of the PEIs-containing blood is also affected. Additonally, the PEIs also have severe impact on the morphology, roughness, and membrane proteins, and inhibit acetylcholinesterase activity of erythrocyte membrane. These findings shed light toward the design of safe PEIs and other biomedical materials by comprehensive preconsideration of their interactions with plasma proteins and blood cell membranes.